-
Notifications
You must be signed in to change notification settings - Fork 1
MGA
MGA acts as a transcriptional repressor and interacts with MYC, a well-known oncogene. Mutations in MGA have been described in DLBCL.1 One study suggested MGA mutations were more common in DLBCLs in patients of African ancestry.2 The mutation pattern in MGA is consistent with a role as a tumour suppressor gene.
%%{init: { 'logLevel': 'debug', 'theme': 'dark' } }%%
timeline
title Publication timing
2017-07-27 : Jallades : MZL
2017-10-10 : Reddy : DLBCL
Entity | Tier | Description |
---|---|---|
2 | relevance in MZL not firmly established[@jalladesExomeSequencingIdentifies2017] | |
1 | high-confidence DLBCL gene[@reddyGeneticFunctionalDrivers2017] |
Entity | source | frequency (%) |
---|---|---|
DLBCL | GAMBL genomes | 4.02 |
DLBCL | Schmitz cohort | 7.23 |
DLBCL | Reddy cohort | 4.70 |
DLBCL | Chapuy cohort | 3.42 |
Entity | aSHM | Significant selection | dN/dS (missense) | dN/dS (nonsense) |
---|---|---|---|---|
DLBCL | No | No | 1.432 | 12.504 |
BL | No | No | 2.443 | 3.733 |
FL | No | No | 0.000 | 0.000 |
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.